HbA1c target attainment

1 paper1 finding

Humans1

Interventions

1

Adjunctive therapy

upin humans1OR 1.73

1 study

Adjunctive therapy improves HbA1c target attainment in humans (OR=1.73, P=0.030).
“The adjunctive therapy group had significantly higher HbA1c target attainment (OR=1.73, P=0.030).”
Humansclassic type 1 diabetesmedian 2.8 yearsn = 312
Effectiveness and Safety of Adjunctive Therapy in Classic Type 1 Diabetes: A Real-World Cohort Study
ADA Scientific Sessions 2026 abstract5 Jun 2026

More on Adjunctive therapy

Latest

2 in 12 months

Journal of Diabetes28 Sep

Effectiveness and Safety of Fixed-Dose Combination Metformin and Empagliflozin in Type 2 Diabetes: A Prospective, Multicenter, Real-World Study From China

Cohort study of 2,602 peopleType 2 diabetes

ADA Scientific Sessions 2026 Abstract6 Jun

Effectiveness and Safety of Adjunctive Therapy in Classic Type 1 Diabetes: A Real-World Cohort Study

Cohort study of 312 peopleType 1 diabetes